Santhosh Palani's most recent trade in Acrivon Therapeutics Inc was a trade of 20,275 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acrivon Therapeutics Inc | Santhosh Palani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Pyxis Oncology Inc | Santhosh Palani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 69,760 | 69,760 | - | - | Stock Option (Right to Buy) | |
| Acrivon Therapeutics Inc | Santhosh Palani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) |